Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > News > Veeco Instruments (NASDAQ:VECO): Buy on Weakness, Short-Term Profit-Taking Provides an Opportunity for Long-Term Investors - J.P. Morgan

May 3rd, 2010

Veeco Instruments (NASDAQ:VECO): Buy on Weakness, Short-Term Profit-Taking Provides an Opportunity for Long-Term Investors - J.P. Morgan

Abstract:
J.P. Morgan is out defending recent high-flier Veeco Instruments (NASDAQ: VECO) this morning reiterating their Overweight rating and $75 price target.

Firm thinks the recent sell-off of VECO is overblown and continues to recommends the stock as their top pick. Although investors are worried about the MOCVD equipment cycle getting too hot and heavy, JPM remains unconcerned about weakness in LED industry fundamentals. They also believe weakness in the stock will be short-lived as they expect news flow over the next few months to be positive for LED demand and drive upside revisions unit demand for LED backlighting and general lighting applications. They are hosting a conference call on Monday morning at 10:30AM EST with the CEO of Veeco, John Peeler.

Source:
streetinsider.com

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

Veeco

Related News Press

News and information

Researchers develop artificial building blocks of life March 8th, 2024

How surface roughness influences the adhesion of soft materials: Research team discovers universal mechanism that leads to adhesion hysteresis in soft materials March 8th, 2024

Two-dimensional bimetallic selenium-containing metal-organic frameworks and their calcinated derivatives as electrocatalysts for overall water splitting March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

Display technology/LEDs/SS Lighting/OLEDs

Light guide plate based on perovskite nanocomposites November 3rd, 2023

Simple ballpoint pen can write custom LEDs August 11th, 2023

Novel design perovskite electrochemical cell for light-emission and light-detection May 12th, 2023

A universal HCl-assistant powder-to-powder strategy for preparing lead-free perovskites March 24th, 2023

Investments/IPO's/Splits

Daikin Industries becomes OCSiAl shareholder July 27th, 2021

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021

180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021

Announcements

What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024

Tools

First direct imaging of small noble gas clusters at room temperature: Novel opportunities in quantum technology and condensed matter physics opened by noble gas atoms confined between graphene layers January 12th, 2024

New laser setup probes metamaterial structures with ultrafast pulses: The technique could speed up the development of acoustic lenses, impact-resistant films, and other futuristic materials November 17th, 2023

Ferroelectrically modulate the Fermi level of graphene oxide to enhance SERS response November 3rd, 2023

The USTC realizes In situ electron paramagnetic resonance spectroscopy using single nanodiamond sensors November 3rd, 2023

Financial Reports

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor February 22nd, 2021

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project